Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,184.69
+5.76 (+0.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Clearside Biomedical Shares Soar On Encouraging Safety Profile For Injectable Axitinib In Wet AMD Patients
June 15, 2021
Clearside Biomedical Inc (NASDAQ: CLSD) has announced positive safety results from Cohort 1 (n=6) of OASIS Phase 1/2a trial of CLS-AX (axitinib injectable...
Via
Benzinga
2 Reasons Why This FDA Decision Could Add Billions to Regeneron's Revenue
June 12, 2021
They have to do with production -- and delivery to the patient.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
Nvidia And Dollar Tree Lead The Nasdaq In A Mixed Day For The Markets
June 11, 2021
U.S. indices had another mixed day of trading following worse-than-expected U.S. jobless figures and inflation data released Thursday.
Via
Benzinga
Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading
June 09, 2021
U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,...
Via
Benzinga
Merck Cuts a Billion-Dollar COVID Deal
June 09, 2021
The U.S. government will pay $1.2 billion for 1.7 billion doses of Merck's experimental oral COVID-19 drug.
Via
The Motley Fool
Exposures
COVID-19
Amazon And Intuit Lead The Nasdaq In A Mixed Day Of Trading
June 08, 2021
U.S. indices had another mixed day of trading Tuesday as investors weighed a weakened 10-year treasury yield and the IRS chief stating that Congres...
Via
Benzinga
FDA Expands EUA for Lower Dose Subcutaneous Version of Regeneron's COVID-19 Antibody Cocktail
June 04, 2021
The FDA has authorized a new, lower-dose version of Regeneron Pharmaceuticals Inc’s (NASDAQ: REGN) COVID-19 monoclonal antibody cocktail for those with...
Via
Benzinga
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
June 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...
Via
Benzinga
Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics
June 03, 2021
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...
Via
Benzinga
This Genetics Stock Could Have a Bright Future
June 03, 2021
Here's one genetics play that you might want to put on your radar.
Via
The Motley Fool
2 Top Value Stocks to Hedge Against Inflation Woes
June 03, 2021
Here are two stocks that can simultaneously add wealth to and protect your portfolio.
Via
The Motley Fool
Topics
Bonds
Exposures
Debt Markets
Novartis Terminates Three Beovu Studies in Ocular Disorders Citing Patient Safety
June 01, 2021
Novartis AG (NYSE: NVS) has announced that three Phase 3 studies evaluating Beovu (brolucizumab) in patients with retinal diseases will be terminated early after...
Via
Benzinga
Regeneron Just Got a COVID-19 Boost
May 29, 2021
It may be short lived.
Via
The Motley Fool
Exposures
COVID-19
The Surprising Move Vir Stock Made After Winning Covid Drug Authorization
May 27, 2021
GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday.
Via
Investor's Business Daily
Exposures
COVID-19
3 Stocks to Build Your Portfolio Around
May 26, 2021
These investments will help you diversify while giving you a good mix of dividends, growth, and stability.
Via
The Motley Fool
Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings
May 24, 2021
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for Regeneron Pharmaceuticals Inc (...
Via
Benzinga
Facebook And Regeneron Lead The Nasdaq Lower Tuesday
May 18, 2021
U.S. indices were trading lower Tuesday after U.S. Treasury Secretary Janet Yellen called for business leaders across the country to pay highe...
Via
Benzinga
Sanofi-Regeneron Tout New Data For Dupixent From Pediatric Asthma Trial
May 17, 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have unveiled detailed results from a Phase 3 trial evaluating Dupixent...
Via
Benzinga
Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know
May 16, 2021
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...
Via
Benzinga
The QQQ Was Hammered Again Today. Here's Why.
May 12, 2021
U.S. indices were trading lower across the board Wednesday after CPI data showed an increase in U.S. inflation, which has weighed on stocks.
Via
Benzinga
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
May 14, 2021
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...
Via
Benzinga
Tesla, Qualcomm Plummet, Lead QQQ Sharply Lower Monday
May 10, 2021
The Nasdaq and companies in the broader technology sector were trading lower Monday amid profit-taking and overall weakness in the sector. Here&rsq...
Via
Benzinga
Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares
May 12, 2021
Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...
Via
Benzinga
Review Of Present Therapies For Covid-19
May 09, 2021
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
Via
Talk Markets
Exposures
COVID-19
ARKK Stocks Breakdowns and Bounces
May 07, 2021
After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.
Via
Talk Markets
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 12, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...
Via
Benzinga
Return On Capital Employed Overview: Regeneron Pharmaceuticals
May 07, 2021
Regeneron Pharmaceuticals (NASDAQ:REGN) posted a 4.65% decrease in earnings from Q4. Sales, however, increased by 4.37% over the previous quarter to $2.53 billion. Despite the...
Via
Benzinga
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
May 10, 2021
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:
Via
Benzinga
Regeneron Pharmaceuticals Inc (REGN) Q1 2021 Earnings Call Transcript
May 06, 2021
REGN earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
May 07, 2021
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.